Internal Medicine, Interventional Cardiology · San Juan, PR
NPI
1992900849
Since 2007
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Centro Cardiovascular de Pr Suite 12, Ave Americo Miranda
San Juan, PR, 00936
Phone (787) 754-6879
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
179 services
Medicare patients, 2024
53
Average age 77
Drug cost, 2024
$133K
2,518 prescriptions
Company payments, 2025
$162K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Damian E Grovas-Abad was code 99213 (office e&m - established), 37 times for 26 patients. In total Damian E Grovas-Abad billed 179 services in 34 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 37 | 26 | $57.78 | $2,138 |
| 99203 Office E&M - New | Office | 30 | 30 | $69.21 | $2,076 |
| 93458 Percutaneous Transcatheterization | Facility | 17 | 17 | $178.06 | $3,027 |
By year: 2022 $29K for 234 services; 2023 $21K for 168 services; 2024 $25K for 179 services.
Medicare prescription drug claims, 2024
In 2024, the drug Damian E Grovas-Abad prescribed most often to Medicare patients was Clopidogrel (Clopidogrel Bisulfate), with 947 prescriptions and refills. In total Damian E Grovas-Abad wrote 2,518 Medicare prescriptions that cost $133K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clopidogrel Clopidogrel Bisulfate | 947 | 1,149 | 372 | $8,312 |
| Cilostazol Generic | 454 | 542 | 185 | $11K |
| Atorvastatin Calcium Generic | 129 | 186 | 48 | $1,223 |
| Xarelto Rivaroxaban | 99 | 111 | 43 | $61K |
| Amlodipine Besylate Generic | 66 | 102 | 19 | $526 |
| Losartan Potassium Generic | 45 | 75 | 14 | $407 |
| Metoprolol Succinate Generic | 41 | 63 | 14 | $506 |
| Carvedilol Generic | 38 | 60 | 15 | $310 |
| Rosuvastatin Calcium Generic | 37 | 49 | 11 | $341 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 36 | 46 | 23 | $355 |
| Chlorthalidone Generic | 35 | 55 | 18 | $721 |
| Eliquis Apixaban | 32 | 42 | 11 | $24K |
| Lisinopril Generic | 32 | 44 | 11 | $197 |
| Ezetimibe Generic | 31 | 39 | Under 11 | $430 |
| Doxazosin Mesylate Generic | 30 | 38 | Under 11 | $350 |
Brand drugs: 183 claims; generic drugs: 2,335 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Damian E Grovas-Abad $162K ($162K in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbott Laboratories with $106K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.